<DOC>
	<DOC>NCT03097185</DOC>
	<brief_summary>Analyze inflammatory markers and islet graft function through blood samples collected from subjects with chronic pancreatitis who undergo total pancreatectomy with auto islet transplantation.</brief_summary>
	<brief_title>Analysis of Graft Function Following Autologous Islet Transplantation</brief_title>
	<detailed_description>A total of 100 subjects will be enrolled in this study; 85 subjects will be enrolled from patients who are scheduled for TP-AIT and 15 subjects will be for TP alone at Baylor University Medical Center at Dallas or Baylor All Saints Medical Center at Fort Worth. The patients who are enrolled in a clinical study, named 'A phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel assignment study to assess the efficacy and safety of reparixin in pancreatic islet auto-transplantation (REP0112, IND# 117390)', can be enrolled in this study.</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis, Chronic</mesh_term>
	<criteria>1. Patients with chronic pancreatitis and who are scheduled for TP alone or TPAIT 2. Patients aged 18 or older 3. Patients are able and willing to attend required followup visits at Baylor 1. Patients who are unable/unwilling to attend followup visits at Baylor 2. For TPAIT subjects: Patients who have advanced stage of chronic pancreatitis. The principal investigator or coinvestigators carefully review the medical charts, laboratory results and radiology department reports and determine the suitability for this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>pancreatitis</keyword>
	<keyword>islet cell</keyword>
</DOC>